A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a ...
A pan-cancer analysis of 8136 TCGA patients found no consistent survival association for functionally prioritized synonymous ...
In HeLa cells, eRF3a degradation amplified aminoglycoside-induced readthrough at MECP2 nonsense mutations but did not trigger ...